Non-selective α2-AR antagonism per se does not seem to be beneficial in reversing NMDA-antagonist-induced cognitive impairment in rodent models (79), while non-selective α2-AR agonism may ameliorate these impairments (80–82). This evidence concerns the gene ADORA2A and Cognitive impairment.